J. Zakrzewski

发表

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

Jan Zakrzewski, Ilana Belitskaya-Lévy, I. Osman, 2010, Clinical Cancer Research.

Association of MDM 2 SNP 309 , Age of Onset , and Gender in CutaneousMelanoma

H. Ostrer, D. Polsky, L. Rolnitzky, 2009 .

Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma

Judith D Goldberg, Jan Zakrzewski, David Polsky, 2009, Clinical Cancer Research.

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

D. Polsky, S. Menéndez, I. Osman, 2009, Proceedings of the National Academy of Sciences.

Meta‐analysis of sentinel lymph node positivity in thin melanoma (≤1 mm)

Jan Zakrzewski, Madhu Mazumdar, David Polsky, 2009, Cancer.

Meta-analysis of sentinel lymph node positivity in thin melanoma (≤ 1mm)

M. Mazumdar, D. Polsky, I. Osman, 2008 .

Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post‐brain metastases survival

M. Mazumdar, D. Polsky, I. Osman, 2011, Cancer.

Shedding of Distinct Cryptic Collagen Epitope (HU177) in Sera of Melanoma Patients

M. Mazumdar, D. Polsky, D. Bajorin, 2008, Clinical Cancer Research.

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

I. Osman, A. Pavlick, M. Segura, 2010, Clinical Cancer Research.

Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post‐brain metastases survival

M. Mazumdar, D. Polsky, I. Osman, 2011, Cancer.